Why the study?
Despite established guidelines and advances in STEMI management, challenges and unanswered questions remain regarding how to improve outcomes.
This review highlights ongoing challenges and unanswered questions in the management of STEMI to guide future research and improve patient outcomes.
Answers are grounded in this paper and cite their sources.
Persistent uncertainties in STEMI management warrant caution; leaves open key questions for future trials.
The management of ST-segment elevation myocardial infarction (STEMI) has evolved significantly over the last decades. STEMI treatment includes reperfusion therapy, ideally by primary percutaneous coronary intervention (pPCI), modern antithrombotic therapy and secondary prevention measures. Even though many areas in the management of STEMI are well studied and analyzed in the guidelines, there are still challenges and unanswered questions on how to improve outcomes. This review aims to offer an insight in areas that need to be explored.
No takes yet. Share an insight, caveat, or question.
Koutsoukis et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: